Synergism of gos and polyfructose

Inactive Publication Date: 2010-03-18
NUTRICIA
View PDF62 Cites 36 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But also the formation of gases, which results in unwanted symptoms such as flatulence and abdominal pain, has been reported when introducing prebiotics, such as inulin or GOS, into the diet.
Furthermore, not only acetate but

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synergism of gos and polyfructose
  • Synergism of gos and polyfructose
  • Synergism of gos and polyfructose

Examples

Experimental program
Comparison scheme
Effect test

example 1

In Vitro Fermentation Studies Show Synergistic Effects on Fermentation Patterns

1.1 Materials and Methods

Microorganisms

[0107]Microorganisms were obtained from fresh faeces from bottle fed babies. Fresh faecal material from babies ranging 1 to 4 month of age was pooled and put into preservative medium within 2 h.

Compositions / Substrate

[0108]As substrate either prebiotics (TOS; TOS (from VivinalGOS, Borculo Domo Ingredients, The Netherlands) and inulin (raftilinHP from Orafti, Belgium) mixture in a 9 / 1 (w / w) ratio; inulin; oligofructose and inulin mixture in a 1 / 1 (w / w) ratio, or none (blanc) was used.

Media

[0109]McBain & MacFarlane medium: Buffered peptone water 3.0 g / l, yeast extract 2.5 g / l. mucin (brush borders) 0.8 g / l, tryptone 3.0 g / l, L-Cysteine-HCl 0.4 g / l, bile salts 0.05 g / l, K2HPO4.3H2O 2.6 g / l, NaHCO3 0.2 g / l, NaCl 4.5 g / l, MgSO4.7H2O 0.5 g / l, CaCl2 0.228 g / l, FeSO4.7H2O 0.005 g / l. 500 ml Scott bottles were filled with the medium and sterilised for 15 minutes at 121° C.

[0110...

example 2

Clinical Study with TOS / Inulin: a Relative Increase of Acetate and Relative Decrease of Butyrate is not Correlated with an Increase of Bifidobacteria. TOS and Inulin have a Synergistic Effect

2.1 Materials and Methods

[0124]63 pregnant woman who had decided to breast-feed and 57 who chose not to, were recruited during their last trimester of pregnancy. Infants with normal birth weight, no congenital abnormality, congenital disease or gastrointestinal disease were enrolled within 3 days after delivery. The study was approved by the ethical committee of the Medical Center, St. Radboud, Nijmegen, The Netherlands. Written informed consent was obtained from the parents before enrolment in the study.

[0125]Infants of mothers who had decided not to breast-feed, were randomly and double blindly allocated to one of two formula groups (OSF, SF). The standard formula group (SF; n=19 received a regular, non-supplemented infant formula (Nutrilon I, Nutricia, The Netherlands). The main compositional...

example 3

Beneficial Effects of Lactate and SCFA Mixture on Muc-2, PGE1 and PGE2 expression

3.1 Material and Methods

[0142]The effect of lactate and a SCFA mixture was analysed as described in Willemsen, L E M, Koetsier M A, van Deventer S J H, van Tol E A F (2003), Gut 52:1442-1447, with the following modifications: Lactate and a mixture of acetate / propionate / butyrate 90 / 5 / 5 was tested. For the mucus production experiments a co-culture of CCD 18 and T84 cells was used, whereas for the PGE1 and PGE2 production experiments a monoculture of CCD18 cells was used.

3.2 Results

[0143]SCFA, in a mixture of 90 / 5 / 5 (acetate / propionate / butyrate), and L-lactate dose dependently induces MUC-2 expression in a co-culture of CCD18 and T84 cells as can be seen in FIG. 4A. Also the concentration of PGE1 and PGE2 increases in CCD18 cells as can be seen in FIG. 4B. At higher concentrations of the added organic acids the increases reaches statistically significance.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Acidityaaaaaaaaaa
Login to view more

Abstract

The present invention relates to the filed of prebiotics. Provided are uses for compositions comprising synergistically effective amounts of polyfructose and galactooligosaccharides (GOS).

Description

FIELD OF THE INVENTION[0001]The present invention relates to the field of human health and nutrition. It provides novel synergistic mixtures of prebiotic carbohydrates, especially mixtures of galacto-oligosaccharides (GOS, for example TOS) and polyfructose (for example inulin), as well as nutritional compositions comprising these. The nutritional compositions have beneficial effects when fed to bottle fed or partially bottle fed infants and also have health improving effects when ingested by adults having intestinal problems, such as Inflammatory Bowel Disease (IBD) or Irritable Bowel Syndrome (IBS).BACKGROUND OF THE INVENTION[0002]The microflora of the human large intestine (typically divided into caecum, colon and rectum) plays a crucial role in both human nutrition and health. The bacterial composition is influenced and can be modulated by dietary intake. Carbohydrates which have passed through the stomach and small intestine are metabolised by the bacteria and as a major end-pro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/715A61P1/00A23L1/09A23L1/30A23L29/244A23L33/00A61K31/01A61K31/702A61K31/733
CPCA23L1/0528A23L1/09A61K31/733A61K31/715A61K31/702A61K31/01A23V2002/00A23L1/296A23L1/30A23L1/3081A61K2300/00A23V2250/28A23V2250/5046A23V2200/3202A23V2250/5062A23V2200/304A23V2200/318A23L29/244A23L29/30A23L33/40A23L33/10A23L33/22A23L5/00A23L7/00A23L33/125A61P1/00A61P1/04A61P1/06A61P1/10A61P1/14A61P17/00A61P21/02A61P29/00A61P3/02A61P37/08
Inventor SPEELMANS, GELSKE
Owner NUTRICIA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap